|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 14/55 | (2006.01) |
| (11) | Number of the document | 3177307 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15750560.3 |
| Date of filing the European patent application | 2015-08-05 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-17 |
| (46) | Date of publication of the claims translation | 2024-08-12 |
| (86) | Number | PCT/US2015/043792 |
| Date | 2015-08-05 |
| (87) | Number | WO 2016/022671 |
| Date | 2016-02-11 |
| (30) | Number | Date | Country code |
| 201462033726 P | 2014-08-06 | US |
| (72) |
MALEK, Thomas , US
|
| (73) |
The University of Miami ,
1951 NW 7th Avenue
Suite 110, Miami, Florida 33136,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Interleukino-2 / interleukino-2 receptoriaus alfa sulietieji baltymai ir panaudojimo būdai |
| INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 11 | 289.00 EUR |
| 2026-08-05 |